This meta-analysis of 10 RCTs (826 patients) compares surgical versus nonsurgical treatment of acute Achilles tendon rupture. The central question: does surgery's historical rerupture advantage persist when modern functional rehabilitation with early range of motion is used in the nonsurgical arm?
For decades, surgery was the default for active patients with Achilles rupture because nonoperative management carried a rerupture rate as high as 10–12% versus under 3% with repair. This paper reframes that calculus entirely: the rehab protocol, not the operative decision, drives rerupture risk.
When your center can deliver functional bracing with early range of motion, offer nonoperative management as a genuine first-line option. Rerupture rates are equivalent to surgery, and you avoid the 15.8% absolute increase in wound, nerve, and thromboembolic complications that comes with the knife.
Reserve surgery for patients at centers using prolonged immobilization, or for those who cannot comply with an early-motion protocol. In that setting, surgery does reduce rerupture risk by ~9% — but counsel patients that roughly 1 in 7 will have a complication, and 2 of every 12 treated will pay for the rerupture benefit with a surgical problem.
The 19-day faster return to work with surgery is real but fragile data. 4 studies, no standardized criteria. Do not let it drive the operative decision without a stronger evidence base.
This meta-analysis of 10 RCTs (826 patients) compares surgical versus nonsurgical treatment of acute Achilles tendon rupture. The central question: does surgery's historical rerupture advantage persist when modern functional rehabilitation with early range of motion is used in the nonsurgical arm?
For decades, surgery was the default for active patients with Achilles rupture because nonoperative management carried a rerupture rate as high as 10–12% versus under 3% with repair. This paper reframes that calculus entirely: the rehab protocol, not the operative decision, drives rerupture risk.
When your center can deliver functional bracing with early range of motion, offer nonoperative management as a genuine first-line option. Rerupture rates are equivalent to surgery, and you avoid the 15.8% absolute increase in wound, nerve, and thromboembolic complications that comes with the knife.
Reserve surgery for patients at centers using prolonged immobilization, or for those who cannot comply with an early-motion protocol. In that setting, surgery does reduce rerupture risk by ~9% — but counsel patients that roughly 1 in 7 will have a complication, and 2 of every 12 treated will pay for the rerupture benefit with a surgical problem.
The 19-day faster return to work with surgery is real but fragile data. 4 studies, no standardized criteria. Do not let it drive the operative decision without a stronger evidence base.